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Abstract: We describe the synthesis of a series of cationic rhodium(I) and iridium(I) compounds 
stabilized by sterically demanding phosphines that contain a terphenyl substituent, PMe2Ar’ (Ar’ = 2,6-
diarylphenyl radical). Salt metathesis of metal precursors [MCl(COD)(PMe2Ar’)] (M = Rh, Ir; COD = 
cyclooctadiene) with NaBArF (BArF = B(3,5-C6H3(CF3)2)4) results in a series of cationic complexes in 
which the loss of the chloride ligand is compensated by the appearance of relatively weak π-interactions 
with one of the flanking aryl rings of the terphenyl substituent. The same experiments carried out with 
carbonyl compounds [MCl(CO)2(PMe2Ar’)] led to the corresponding cationic carbonyl complexes, 
whose CO-induced rearrangement reactivity has been investigated, both experimentally and 
computationally. The differences in reactivity between rhodium and iridium complexes, and as a result 
of varying the sterics of terphenyl phosphines are discussed. 
Introduction 
Phosphines are among the most widely used ancillary ligands in coordination and organometallic 
chemistry, largely due to the possibility of finely modulating their steric and electronic properties in a 
predictable manner.1 The range of physicochemical properties of transition metal complexes that can be 
tuned by the judicious choice of a phosphine ligand is exceptional. In particular, phosphines that contain 
bulky substituents have been successfully applied to stabilize a variety of low-coordinate transition 
metal complexes2 with important implications in catalysis.3 A notorious example is found in the work of 
Buchwald and coworkers, who synthesized in 19984 the first example of a currently extensive family of 
biaryldialkyl phosphines. 
The use of biaryl phosphines in homogeneous catalysis has found great success, particularly in 
palladium-catalysed cross coupling5 and amination reactions.6 Catalytic applications that rely on the 
combination of biaryl phosphines with iridium7 and rhodium8 precursors have also been described, 
although to a lesser extent. In a prominent example, Hartwig and co-workers demonstrated that the 
combination of [Rh(COD)2]BF4 (COD =  1,5-cyclooctadiene) and a biaryldialkyl phosphine functions 
as an excellent catalytic mixture for the intramolecular hydroamination of inactivated alkenes under 
mild conditions,9 with the active species containing the phosphine ligand bound to rhodium in a κ1,η6 
  
 
 
coordination mode (A in Scheme 1).10 The group of Goldberg has investigated the chemistry of related 
rhodium complexes where the flanking aryl ring of several biaryl phosphines coordinates to the metal 
centre with variable hapticity. 11  These studies were later extended to the corresponding iridium 
systems. 12  While rhodium designs were active catalysts for arene hydrogenation,11 their iridium 
counterparts revealed their potential for transfer hydrogenation reactions.12 More recently, the 
usefulness of Rh/biaryl phosphine combinations for the selective and catalytic functionalization of C-H 
bonds has been disclosed.13 
 
 
 
 
 
 
 
Scheme 1. (a) Key intermediate A in the Hartwig’s Rh-mediated hydroamination of alkenes; (b) 
Terphenyl phosphine ligands employed in this work. 
 
The ability of biaryl phosphines to function as hemilabile ligands by means of dynamic π-arene 
coordination seems to be crucial for its success in catalysis.6a,14 Although this type of coordination 
enhances the stability of the active species, catalyst decomposition remains a major limitation, as 
observed in Goldberg11 and Hartwig’s10, 15  systems. With this in mind, it is surprising that 
terphenyldialkyl phosphines,16 in which the biaryl substituent is replaced by a sterically more crowded 
terphenyl (2,6-diarylphenyl) group, have not been examined in deeper detail. We recently embarked to 
explore this type of ligands,17 demonstrating their potential to stabilize otherwise elusive organometallic 
frameworks.18 This work extends these studies to cationic rhodium and iridium systems bearing 1,5-
cyclooctadiene and ethylene ligands. Thus, we analyse the coordination modes of two terphenyl 
phosphine ligands, namely PMe2Ar
Xyl2 and PMe2Ar
Dipp2 (Scheme 1). In addition, we have synthesized 
rhodium and iridium cationic derivatives where the olefins have been substituted by CO ligands, and 
have observed a CO-induced ligand rearrangement in which phosphine hemilability plays a key role. 
Results and Discussion 
  
 
 
Synthesis of Rh(I) and Ir(I) olefin compounds. 
 
Salt metathesis of chloride complexes 1 (1a: Ar’ = PMe2ArXyl2; 1b: Ar’ = PMe2ArDipp2), cleanly 
prepared by the 1:1 reaction of [RhCl(COD)]2 and the corresponding terphenyl phosphine,17
a with 
NaBArF (BArF = B(3,5-C6H3(CF3)2)4) in dichloromethane, afforded cationic complexes 2 quantitatively 
(Scheme 2). Chloride abstraction in compounds 1 triggers η6-coordination of the π-system of one of the 
flanking aryl substituents of the phosphine, forcing the COD ligand to change its bidentate η2:η2-
coordination mode to monodentate η2-binding. Whereas there are examples of a phosphine aryl 
substituent coordinating to Rh(I) and Ir(I) in the η6-mode while maintaining the M—P bond,10,11,12 
only a few complexes of these metals that exhibit monodentate COD ligand coordination have been 
reported. To our knowledge, prior to this work, no complexes of this kind had been structurally 
characterized for rhodium.19 
 
 
 
 
 
 
 
Scheme 2. Synthesis of cationic rhodium complexes 2 by chloride abstraction from 1. 
 
The formulation proposed for complexes 2 in Scheme 2 was ascertained by NMR spectroscopy studies 
in solution and, in the case 2a, also by X-ray crystallography. In the 31P{1H} NMR spectrum, a doublet 
at ca. 48 ppm, with a relatively large 1JPRh coupling of 192 Hz was observed for both 2a and 2b. 
Complex 2a shows fluxional behaviour in solution, as inferred from the presence of some broad signals 
in the 1H NMR spectrum recorded at 25 ºC (500 MHz, CD2Cl2). Cooling at 0 ºC allowed freezing the 
structure pictured in Scheme 2 on the NMR time scale, thereby permitting assigning all the 1H and 13C 
NMR resonances in their respective spectra (see Supporting Information). Two of the aromatic proton 
resonances of compounds 2 appear somewhat shielded at around 6.7 (d, 2 H, 3JHH ca. 7.5 Hz) and 5.9 
ppm (t, 1 H, 3JHH ca. 7.5 Hz), in accordance with the proposed η6-coordination of one of the flanking 
aryl substituent of the terphenyl group. This is in contrast with corresponding resonances being found 
above 7.2 ppm for the analogous H atoms in the free lateral ring. In the 13C{1H} NMR spectrum of 2a, 
  
 
 
the associated 13C nuclei appear at 112.1 and 97.1 ppm for the Rh-bonded xylyl, and at 128.6 and 127.8 
ppm for the non-coordinated xylyl substituent, and the same pattern is found for 2b. A similar 
dichotomy was found between these NMR parameters of the olefinic =CH groups of the COD ligand, 
with the proton and carbon nuclei of the Rh-bonded –CH=CH– moiety in 2 resonating at 3.38 and 74.0 
ppm (d, 1JCRh = 13 Hz) respectively, and those corresponding to the uncoordinated C=C bond at 5.55 
and around 130 ppm. 
At variance with 2a, compound 2b, based on the bulkier PMe2Ar
Dipp2 phosphine, led to sharp signals in 
its corresponding 1H NMR spectrum, with no sign of fluxionality on the NMR time scale. A plausible 
explanation for the dynamic behaviour of 2a could be the accomplishment of a fast dynamic 
equilibrium with unobserved amounts of an isomer featuring η2-coordination of the xylyl ring and 
bidentate η2:η2-binding of the COD ligand at 25 ºC. In fact, this latter structure was the preferred isomer 
in a related complex based on [(2-biphenyl)dicyclohexylphosphine] (CyJohnPhos).11 Taking in mind 
the importance of these π-arene interactions in catalysis, it is interesting to note that the prevalence of a 
particular π-coordination mode in these rhodium complexes containing biaryl or terphenyl phosphines 
may be modulated by the choice of the phosphorus ligand. 
The proposed dynamic exchange between η2- and η6-coordination modes of the arene substituent is 
further supported by investigations on the analogous iridium system. Chloride abstraction by NaBArF 
from two iridium(I) compounds of formula [IrCl(COD)(PR2Ar’)] (3a: Ar’ = PMe2ArXyl2, and 3b: Ar’ = 
PMe2Ar
Dipp2)17a proceeded readily to yield cationic species 4 and 5. As depicted in Scheme 3 the 
equilibria between these complexes result from hapticity changes within both the flanking arene of the 
terphenyl substituent (κ1 vs. η6) and the COD ligand (η2:η2 vs. η2). The equilibrium for 4a seems to be 
more rapid than in the rhodium analogue 2a, as inferred from the sharp resonances detected in the 
corresponding NMR spectra, and was confirmed by the presence of several exchange peaks in 2D 
EXSY experiments (see Figure S16). The isomeric distribution is phosphine dependent, with the smaller 
PMe2Ar
Xyl2 leading to isomer 4a as the major component (4a:5a; 59:41 ratio), whereas the more 
sterically congested PMe2Ar
Dipp2 preferring COD η2, monodentate coordination accompanied by η6-
coordination of the flanking Dipp ring (4b:5b; 14:86 ratio). 
 
 
 
 
Scheme 3. Synthesis of complexes 4 and 5 by chloride abstraction from compounds 3. 
  
 
 
 
The nature of isomers 4 and 5 was postulated on the basis of NMR spectroscopy, although the 
formulation of 4a was further confirmed by X-ray studies. Compounds 4 present a 31P{1H} resonance at 
around 15 ppm, slightly deshielded (ca. 2 ppm) relative to their η2-COD isomers 5. In the latter, η6-
coordination of the flanking arene is ascertained by the somewhat upfield signals at 6.6 (d, 2 H, 3JHH = 6 
Hz) and 5.7 (t, 1 H, 3JHH = 6 Hz) ppm. The two distinctive peaks recorded at around 5.6 and 2.9 ppm 
due to the COD fragment evince that only one of the two olefinic moieties is bound to iridium. In 
contrast, a set of two resonances in the interval 3.2 to 3.4 ppm in compounds 4 is consistent with the 
η2:η2-coordination proposed for COD. In fact, this latter formulation is similar to that previously 
reported for related iridium complexes based on biaryldialkyl phosphines.12 For this system, however, 
isomers alike 5 were not detected and no sign of solution equilibrium was noticed. 
The addition of pyridine to the equilibrium mixture 4a/5a results in quantitative formation of compound 
6a, a sterically encumbered version of the widely used Crabtree’s catalyst (Scheme 4).20 The latter, as 
well as many other cyclooctadiene Ir(I) compounds bearing phosphine ligands, have found ample use in 
catalysis,21 highlighting the potential of compounds alike 6a for these purposes. This is a research 
avenue that we are currently pursuing in our laboratories. The κ1-P monodentate coordination of the 
phosphine in 6a is confirmed by the symmetric pattern observed for its deshielded (7.1 – 7.6 ppm) 
aromatic 1H NMR resonances, and by the presence of two signals, each corresponding to two protons, at 
3.49 and 3.98 ppm, denoting η2:η2-coordination of cyclooctadiene. In turn, the corresponding 31P{1H} 
NMR band of 6a appears at lower frequency (-12.1 ppm) than in isomers 4a (16.9 ppm) and 5a (2.0 
ppm), i. e. shifted to higher frequency by only ca. 30 ppm relative to free phosphine. 
 
 
 
 
 
 
 
 
Scheme 4. Synthesis of pyridine adduct 6a. 
 
  
 
 
As anticipated, the solid state structures of complexes 2a and 4a were confirmed by single crystal X-ray 
studies. Figure 1 depicts the molecular structures of the cations of 2a and 4a. As can be seen in the 
structure of 2a, its Rh(I) centre is formally five-coordinate to one of the C=C bonds of COD (C1—C2), 
one of the flanking η6-aryl ring (C7 – C12), and the phosphorus atom of the phosphine ligand. The Rh-
η2-COD linkage is characterized by Rh—C bonds with length ca. 2.15 Å, comparable to other known 
Rh(I)-alkene units. The Rh(I)-η6-arene moiety presents, however, relatively long Rh—C bonds, with the 
exception of the Rh-Cipso contact (Rh1—C15 in Figure 1), which at 2.142(4) Å is practically identical to 
the Rh—COD bond distances. The remaining Rh—C bonds to the η6-aryl ring have lengths in the range 
2.30-2.35 Å. These separations are similar to, albeit somewhat longer, than those reported for other 
Rh(I)-arene complexes.22 This coordination mode clearly differs from that of 4a, where the geometry 
around iridium is square planar, encompassing binding to phosphorus, η2:η2-coordination to COD and a 
κ1, π-arene interaction with a flanking aryl ring. The Ir-C bond distances within the Ir-η2-COD 
fragments have normal values, with those in trans to phosphorus being slightly elongated (ca. 2.24 Å) 
with respect to those trans to the π-arene interaction (ca. 2.12 Å), as a result of the stronger trans 
influence of the phosphine. At variance with previous related systems based on biaryl phosphines that 
exhibit η2-arene coordination defined by two close M-Carene distances,11,12 the terphenyl phosphine of 
complex 4a is mainly coordinated through the phosphorous terminus and through the ipso carbon atom 
of a lateral aryl ring (Figure 1). The latter interaction is relatively strong, with an Ir1–C7 contact of 
2.308(4) Å that supports κ1-P, κ1-Carene phosphine binding.23 Nonetheless, a slim tilt is noticeable in the 
interacting aryl substituent, and this distortion breaks the symmetry along the Ir-π-arene moiety 
facilitating the approach of one of the ortho carbon atoms. As a result, an Ir1–C8 contact of 2.609(7) Å 
can be measured, which is significantly shorter than the Ir1–C12 separation of 2.878(8) Å to the other 
ortho carbon atom. In principle, a non-symmetrical η2-coordination of the anchored arene cannot be 
disregarded.24 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. ORTEP view of the cations of complex 2a and 4a; hydrogen atoms are excluded for clarity 
and thermal ellipsoids are set at 50% level of probability. 
 
To complete this series of Rh(I)/Ir(I) olefin compounds we targeted ethylene structures analogous to 
Hartwig’s key intermediate in hydroamination reactions (A in Scheme 1).10 Accordingly, the ethylene 
rhodium (7) and iridium (8) adducts, closely related to complexes 2 and 5, respectively, were cleanly 
obtained from the reactions of the corresponding dimers [MCl(C2H4)2]2 (M = Rh, Ir) with NaBArF in 
the presence of the phosphine (CH2Cl2, 25 ºC, Scheme 5). Addition of NaBArF proved essential to 
favour quantitative formation of the desired ethylene adducts, as in its absence, cationic compounds 7 
and 8 with chloride as counteranion formed along with various other species containing a metal-bound 
chloride ligand. Once more, the new compounds were characterized by microanalysis and NMR 
spectroscopy. The 1H and 13C{1H} NMR spectra are in accord with the proposed η6-coordination of one 
of the phosphine aryl substituents. In turn, in rhodium compounds 7, the ethylene ligand undergoes fast 
rotation on the NMR time scale at 25 ºC, such that the four hydrogen atoms give rise to broad 1H NMR 
resonances at around 2.9 ppm, while the 13C nuclei resonate as a doublet in the proximity of 46 ppm 
(1JCRh = 13 Hz). Ethylene rotation is hindered in their iridium analogues, reflecting the stronger Ir-η2-
C2H4 bond when compared to Rh-η2-C2H4 bond due to the iridium higher basicity. This fact is 
  
 
 
evidenced by two distinctive signals at around 1.7 and 3.0 ppm due to the ethylene ligand in the 1H 
NMR spectra of compounds 8. The corresponding 13C{1H} NMR resonance appears at ca. 24 ppm. The 
13C signals of the C2H4 ligand in complexes 8 are therefore shielded by more than 20 ppm with respect 
to those in the rhodium analogues, evincing a higher sp3 character of the carbon atoms as a consequence 
of increased π-back donation from the Ir(I) centre. It is widely accepted that the low-frequency shift of 
the olefin carbon atoms relative to free ethylene (122.8 ppm) increases with π-back bonding.25 The 
structure of compound 7b was authenticated by X-ray diffraction studies (Figure S5). The bound 
ethylene molecule presents a C-C bond distance of 1.386(6) Å, nearly identical to that of the related 
ethylene adduct reported by Hartwig (A in Scheme 1)10 and close to the 1.37 Å distance in Zeise’s 
salt.26 The remaining geometric parameters are essentially similar to those measured in structures A and 
2a. 
 
 
 
 
 
 
Scheme 5. Synthesis of complexes 7 and 8. 
 
Synthesis of rhodium and iridium carbonyl compounds 
 
Substitution of cyclooctadiene by two CO ligands in this type of complexes has been amply utilized to 
gauge the electronic properties of ancillary ligands,27 particularly bulky phosphines, as well as to access 
catalysts with enhanced performance.28 For instance, using this method we proved that the basicity of 
terphenyl phosphines PMe2Ar
Xyl2 and PMe2Ar
Dipp2 is comparable to that of the related widely employed 
PR2Ar biarylphosphines.
17,29 
We now decided to extend the chemistry of our neutral carbonyl compounds to more reactive cationic 
rhodium and iridium derivatives, once again by means of chloride abstraction. Treatment of CH2Cl2 
solutions of 9 and 10 with NaBArF cleanly generated the desired cationic carbonyl complexes, although 
the outcome of the reaction was dependent on the selected metal. For instance, under the conditions of 
Scheme 6, rhodium precursors 9 led to monocarbonyl compounds 11·CO, whereas the iridium analogs 
provided dicarbonyl complexes 12·(CO)2 (Scheme 6). Once again, abstraction of the chloride ligand by 
  
 
 
the Na+ cation created a vacant coordination site that was occupied by a flanking aryl ring of the 
phosphine. In the rhodium system η6-arene coordination was preferred, which along with phosphine 
bonding resulted in a (2+6)-electron binding mode that caused concomitant dissociation of one of the 
original carbonyl groups and formation of the formally five-coordinate 18-electron complexes 11·CO. 
On the contrary, the two carbonyl ligands remained bound to iridium in compounds 12·(CO)2, and 
chloride elimination was simply compensated by a κ1-Carene coordination of a flanking aryl substituent, 
as occurs in compounds 4. The dissimilar behaviour of the two systems may reflect once more the 
higher basicity of Ir(I) with respect to Rh(I), resulting in increased back donation to carbonyl ligands 
and stronger M-CO bonds. 
 
 
 
Scheme 6. Synthesis of complexes 11·CO and 12·(CO)2. 
 
As expected, a single ν(CO) intense band at around 2015 cm-1 appears in the IR spectra of compounds 
11·CO, while dicarbonyl compounds 12·(CO)2 are characterized by two strong bands at ca. 2094 and 
2027 cm-1, respectively assigned to the antisymmetric and symmetric stretching vibrations of the CO 
groups. The molecular formulation of complexes 11·CO and 12·(CO)2 was also ascertained by means 
of NMR spectroscopy. The proposed η6-coordination of the flanking aryl unit in the rhodium complexes 
is supported by the comparison of the 1H and 13C{1H} NMR spectra with those of the related species 2 
and 7. In addition, the carbonyl ligand of complexes 11·CO is responsible for a distinctive 13C 
  
 
 
resonance at 183 ppm (dd, 1JCRh ≈ 95, 2JCP ≈ 18 Hz) while the 31P{1H} spectrum consists of a doublet at 
49.3 ppm (1JPRh ≈ 169 Hz). The presence of two carbonyl groups in compounds 12·(CO)2 is evinced by 
two resonances at around 183 (d, 2JCP = 102 Hz) and 163 (d, 
2JCP = 14 Hz) ppm due respectively to the 
ligands oriented trans and cis to the phosphine. Distinctive 13C NMR resonances at ca. 118 ppm (d, 2JCP 
= 3 Hz) due to the ipso carbon atoms of one of the flanking aryl rings in compounds 12·(CO)2 are 
indicative of the existence of a weak κ1-interaction with the metal to compensate for chloride 
abstraction.30 
Complexes 11a·CO and 12b·(CO)2 were also characterized by single crystal X-ray studies (Figure 2). 
The overall structures are similar to those previously discussed for complexes 2a and 4a, respectively. 
The molecules of 11a·CO have a Rh1—P1 bond essentially identical (2.2338(17) Å) to the Rh—P bond 
of 2a and to that present in related complexes containing η6, 1-arene-phosphine ligands.10,31 There are 
some small differences in the Rh-η6-arene linkages of complexes 2a and 11a·CO, as in the latter the 
Rh—Carene contacts are somewhat longer. Similar to 2a, the Rh—Cipso bond exhibits the shortest 
separation (Rh1—C8 = 2.163(5) Å), but the remaining Rh—Carene bonds span over the range ca. 2.31-
2.39 Å. The Rh—CO bond features regular metrics (Rh1—C1 = 1.846(6) Å; C1—O1 = 1.145(8) Å). 
The proposed κ1-coordination of the flanking arene in 12b·(CO)2 is confirmed by a short Ir1—C7 
contact of 2.297(9) Å involving the ipso carbon of the π-aryl group. Similarly to the structure of 4a, this 
ring is slightly slanted in such a manner that one of the adjacent carbon atoms (Ir1—C8 = 2.571(4) Å) is 
closer to the iridium centre than the other one (Ir1—C12 = 2.742(4) Å). 13C{1H} NMR data and the 
noticeable shorter Ir-Carene contact to the ipso carbon already alluded to favour κ1-Carene coordination, 
which is further supported by calculations, more precisely by means of the quantum theory of atoms in 
molecules QTAIM calculations32 (see Supporting Information for details). 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 2. ORTEP view of the cations of complexes 11a·CO and 12b·(CO)2; hydrogen atoms are 
excluded and isopropyl groups are represented in wireframe format for clarity, while thermal ellipsoids 
are set at 50% level of probability. 
 
Compounds 11·CO were isolated in good yields as air stable orange powders that remained unaltered 
for long periods of time. Their iridium counterparts, however, underwent in solution an interesting 
rearrangement of the carbon monoxide ligands. Thus, dichloromethane solutions of compound 
12a·(CO)2 underwent spontaneous iridium-carbonyl disproportionation to 1:1 mixtures of the 
monocarbonyl species 12a·CO, that is, the iridium version of the aforementioned compound 11a·CO, 
and the tricarbonyl complex 12a·(CO)3 (Scheme 7). The reaction was readily monitored by 31P{1H} 
NMR spectroscopy. Resonances corresponding to complexes 12a·CO (6.7 ppm) and 12a·(CO)3 (-20.2 
ppm) gradually appeared shifted to higher fields when compared to 12a·(CO)2 (16.2 ppm). Kinetic 
analysis of this rearrangement revealed a first-order dependence on dicarbonyl compound 12a·(CO)2 at 
room temperature characterized by a first-order rate constant of 2.5·10-4 s-1, which corresponds to 
ΔG‡298 ≈ 22.3 kcal·mol-1 and t1/2 ≈ 45 min (see Supporting Information for details). This finding points 
out to a stepwise mechanism in which CO dissociation appears to be the rate limiting step. Coordination 
of the liberated CO to still unreacted 12a·(CO)2 would rapidly yield the tricarbonyl species 12a·(CO)3. 
In accordance with this proposal, exposure of dichloromethane solutions of 12a·(CO)2 to carbon 
monoxide (1.2 bar, 25 ºC) results in immediate and quantitative formation of 12a·(CO)3. DFT 
calculations support these findings and show a free energy barrier of 18.3 kcal·mol-1 for CO 
dissociation from 12a·(CO)2 to yield 12a·CO and CO (+8.3 kcal·mol-1), which can be captured by 
12a·(CO)2 through a low barrier of 7.8 kcal·mol-1 to afford 12a·(CO)3 (see Figure 4 below and the 
Supporting Information for details). The latter species is predicted to be the most stable 
thermodynamically (-9.5 kcal·mol-1 from 12a·(CO)2 + CO). 
 
  
 
 
 
 
 
 
 
 
Scheme 7. Solution rearrangement of the carbonyl ligands of complex 12a·(CO)2. 
 
Compounds 12a·CO and 12a·(CO)3 were synthesized independently (see Experimental Section) and 
their structures ascertained by spectroscopic methods and X-ray diffraction studies. As expected, 
compound 12a·CO exhibits an intense band in its IR spectrum at 2000 cm-1 due to the carbonyl ligand, 
shifted by almost 20 cm-1 at lower frequency in comparison with the rhodium analog 11a·CO. In turn, 
tricarbonyl compound 12a·(CO)3 gives rise to two bands at 2126 and 2027 cm-1, in agreement with 
previous compounds of formula [Ir(CO)3PR3]
+.33 Overall, the average bond stretching frequencies for 
the three iridium compounds depicted in Scheme 7 follow the order 12a·(CO)3>12a·(CO)2>12a·CO, in 
accordance with the distribution of electron density donated by the Ir(I) centre to the π* antibonding 
orbital of the CO ligands. 
The 1H and 13C{1H} NMR spectra of the new compounds are also in agreement with the proposed 
formulation. A 13C{1H} NMR resonance due to the carbonyl ligand in 12a·CO has been recorded at 
167.2 ppm (d, 2JCP = 2 Hz), while for compound 12a·(CO)3 two signals at 173.1 (d, 
2JCP = 15 Hz) and 
168.2 (d, 2JCP = 88 Hz) ppm can be assigned to the CO ligands cis and trans to the phosphorus atom. η6-
Arene coordination in 12a·CO becomes notorious after analysing its 1H and 13C{1H} NMR data. 
Moreover, its nature was authenticated by X-ray diffraction studies (Figure 3), which revealed a 
structure closely similar to that of its rhodium counterpart 11a·CO. On the contrary, examination of the 
spectroscopic data recorded for complex 12a·(CO)3 did not provide definitive evidence for the 
existence of weak interactions with the aryl substituents of the phosphine.30 The two flanking aryl rings 
of the terphenyl fragment appear equivalent at room temperature on the NMR time scale. Nevertheless, 
12a·(CO)3 exhibits dynamic behaviour in solution due to rapid exchange of the two phosphine aromatic 
rings, with a coalescence temperature of around -60 ºC measured in the variable temperature 1H NMR 
spectrum (see Figure S12 in the Supporting Information). Besides, noticeable exchange peaks were 
observed in 2D-EXSY experiments. The 13C{1H} NMR resonance due to the rapidly exchanging ipso 
carbon atoms of the xylyl substituents appears slightly shielded (132.3 ppm) when compared to non-
  
 
 
coordinated xylyl rings (ca. 136 ppm). In the solid state, complex 12a·(CO)3 adopts a distorted square 
planar geometry, as determined by X-ray diffraction studies. One of the phosphine lateral xylyl rings 
approaches the metal from an apical position and forces the CO groups cis to the phosphine to bend 
towards one another, enforcing a distorted trigonal bipyramid arrangement around iridium (OCcis—Ir—
COcis = 147.17(6)º). The shortest contact between iridium and the proximal xylyl ring occurs through 
the ipso carbon atom at a distance of 2.523(6) Å (Ir1—C7). This separation, albeit longer than in 
complexes 12a·CO and 12a·(CO)3, can be taken as indicative of a weak κ1-Carene interaction in the 
solid-state structure.23 The DFT-optimized geometry of 12a·(CO)3 is consistent with this arrangement, 
and topological analysis revealed the existence of a bond critical point and a unique bond path between 
the iridium and the ipso carbon atoms (see SI for details). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. ORTEP view of the cations of complexes 12a·CO and 12a·(CO)3; hydrogen atoms are 
excluded for clarity and thermal ellipsoids are set at 50% level of probability. 
 
Despite many similarities, the carbon monoxide chemistry of the related iridium system bearing the 
bulkier PMe2Ar
Dipp2 phosphine revealed some subtle differences. For example, when dichloromethane 
  
 
 
solutions of 12b·(CO)2 were allowed to stand at room temperature for several days, the only discernible 
product was the monocarbonyl derivative 12b·CO, even if the reaction
Figure 4. Free energy profile for CO dissociation and capture in compounds 12a·(CO)n (n = 1-3; R= 
Me, dashed line) and 12b·(CO)n (n = 1-3; R= iPr, solid line)  calculated at the (ωB97X-D/cc-pVTZ-
SDD//ωB97X-D/6-31G(d,p)-SDD) level of theory with solvent corrections (SMD, CH2Cl2). 
 
 
  
 
 
was monitored in a sealed NMR tube. It soon became clear that, at variance with the system based on 
PMe2Ar
Xyl2, complex 12b·(CO)2 is unable to trap at a reasonable rate the carbon monoxide it might 
eventually dissociate. In support of this, DFT calculations (Figure 4) reveal that CO capture by the latter 
species has a barrier 6.2 kcal·mol-1 higher than that found for its less hindered counterpart 12a·(CO)2. 
Tricarbonyl complex 12b·(CO)3 is again predicted by DFT to be the most stable of the three 12b·(CO)n 
species (-2.6 kcal·mol-1 from 12b·(CO)2 + CO) and could, indeed, be quantitatively prepared by 
exposure of its mono or dicarbonyl precursors to an excess of CO (1.2 bar, CH2Cl2, 25 ºC, 10 min). 
According to the full spectroscopic characterization (IR and NMR) of these new compounds, their 
structures are analogous to those depicted in Scheme 7. The chemical formulation of compound 
12b·CO was further verified by single crystal X-ray studies. The geometric features determined are 
essentially alike those in the related xylyl phosphine system (see Figure S9). Regarding complex 
12b·(CO)3, variable temperature NMR studies evidenced a fluxional behaviour similar to that discussed 
above for 12a·(CO)3, with a nearly identical coalescence temperature. In this case, the DFT-optimized 
geometry of 12b·(CO)3 is distorted from that of 12a·(CO)3, probably due to steric hindrance between 
the isopropyl substituents and the carbonyl groups, shifting the closest Ir-Carene interaction to the ortho 
carbon (see SI for details). Monitoring the evolution of 12b·(CO)2 by 31P{1H} NMR spectroscopy at 25 
ºC provided kinetic information for the formation of monocarbonyl species 12b·CO (k1 = 1.2·10
-5 s-1, 
ΔG‡298 ≈ 24.1 kcal·mol-1, t1/2 ≈ 16h; see SI for details), clearly reflecting the slower dissociation rate of 
carbon monoxide when compared to the system constructed around PMe2Ar
Xyl2 (22.1 vs. 18.3 kcal·mol-
1 according to the calculations). 
To complete these studies we decided to explore whether the analogous cationic carbonyl rhodium 
compounds would exhibit similar rearrangement chemistry. Although exposure of complexes 11·CO to 
1 bar of carbon monoxide did not result in the formation of the expected tricarbonyl compounds, some 
interesting observations were disclosed when somewhat higher CO pressures (6 bar) were employed. 
The chemical changes were monitored by 1H, 31P{1H} and 13C{1H} NMR spectroscopy at variable 
temperature (from 25 to -60 ºC) and are summarized in Scheme 8. As can be seen, attainment of a fast 
equilibrium on the laboratory time scale between the starting monocarbonyl complex 11·CO and 
tricarbonyl species 11·(CO)3 is proposed. Naturally, equilibria of this type are temperature dependent, 
with low temperatures disfavouring CO dissociation from 11·(CO)3 and formation of the monocarbonyl 
compounds 11·CO, which exhibit in addition full phosphine chelation, i. e. κ1-P:η6-arene coordination 
of the terphenyl phosphine ligand. The variable temperature 13C{1H} NMR studies to be discussed next 
back strongly this proposal. Likewise, variable temperature 31P{1H} NMR experiments using complex 
11a·CO are also in accordance with the equilibrium represented in Scheme 8 and reveals besides that 
the tricarbonyl derivative exists in equilibrium with minor concentrations of a closely related complex. 
This equilibrium is fast on the NMR time scale and can only be frozen at temperatures below -50 ºC 
  
 
 
(Figure S11). It is important to mention that removal of CO under vacuum displaces the equilibrium of 
Scheme 8 toward the left, allowing quantitative recovery of the monocarbonyls 11·CO. 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 8. Solution equilibria between complexes 11·CO and 11·(CO)3 under a CO atmosphere (6 bar, 
CD2Cl2, 25 ºC to -60 ºC). 
 
Figure 5 contains 13C{1H} NMR spectra of CD2Cl2 solutions of complex 11a·(CO)1 recorded at 25, -40 
and -60 ºC, under 6 bar of CO. For the sake of simplicity only the most informative carbonyl and 
aliphatic regions of the spectrum are shown (roughly 185-176 and 24-16 ppm, respectively). With 
reference to the room temperature spectrum, the monocarbonyl 11a·CO exhibits the expected doublet-
of-doublet carbonyl resonance centred at 183.2 ppm, a PMe2 doublet signal at 19.1 ppm (d, 
1JCP = 37 
Hz) and Me(Xyl) singlets with  22.0 and 20.3 ppm. In addition, there is a broad hump centred at ca. 
182.1 ppm and a singlet at 22.4 ppm that are attributed to the CO ligands and Me(Xyl) groups, 
respectively, of the purported tricarbonyl 11a·(CO)3. The signal due to the PMe2 groups of the 
phosphine is very broad and can be conjectured to be located at 19.5 ppm, practically hidden into the 
base-line. Upon cooling, this signal becomes clearly discernible and appears at 18.5 ppm (d, 1JCP = 37 
Hz) in the -60 ºC spectrum. At the latter temperature, the broad signal of the CO ligands of 11a·(CO)3 
centred at ca. 182.1 ppm, resolves into two doublet-of-doublet resonances in a ca. 2:1 ratio, observed at 
180.6 (1JCRh = 69, 
2JCP = 16 Hz) and 178.8 ppm (
1JCRh = 51, 
2JCP = 92 Hz), attributable respectively to 
two cis and one trans carbonyl groups, relative to the phosphine ligand. The low ratio of the 
PMe2Ar
Dipp2 complex 11b·(CO)3 (<5% at -60 ºC) precluded performing a similar analysis based on 13C 
NMR spectroscopy. 
In turn, the room temperature 31P{1H} NMR spectrum (Figure S11) shows a sharp doublet for 11a·CO 
with 49.3, along with a broad signal centred at about -2.30 ppm. Upon cooling, the latter resonance 
  
 
 
becomes gradually resolved, and at -60ºC it converts into a main doublet resonance at -1.21 ppm (1JPRh= 
91 Hz) that can be reasonably attributed to 11a·(CO)3 (Scheme 8), along with a considerably less 
intense doublet at -3.6 ppm, exhibiting a one-bond 31P-103Rh coupling constant of 117 Hz. In the 
meantime, the 49.3 ppm doublet featuring a 1JPRh coupling constant of 167 Hz remains unchanged 
(Figure S11). 
Although by similarity with the analogous iridium system it may be tempting to propose that the less 
intense, lowest frequency doublet registered at -2.30 ppm could be due to small concentrations of a 
dicarbonyl species 11a·(CO)2 related to the iridium complex 12a·(CO)2 of Scheme 7, the close 
correspondence of the NMR parameters found for the major and minor, rapidly interchanging species, 
suggest instead that they feature comparable molecular complexity. For all compounds investigated in 
this work, implication of a lateral aryl group of the terphenyl radical in the bonding to the metal centre 
causes deshielding of the 31P{1H} NMR resonance. On this basis we suggest that the more intense 
doublet at -1.21 ppm may be due to complex 11a·(CO)3 with bidentate phosphine binding through the 
phosphorus and one of the ipso carbon atoms of the terpehenyl substituent, whereas the signal with 
reduced intensity, slightly shifted to lower frequency (-3.6 ppm), corresponds to an isomeric four-
coordinate complex in which the phosphine behaves as a monodentate ligand through the P atom. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Variable temperature 13C{1H} NMR spectra, in the carbonyl and aliphatic regions, of 
complex 11a·CO under 6 bar of CO (100 MHz, CD2Cl2, -60 ºC to 25 ºC). 
Conclusions 
The reactivity found out for the reported Rh(I) and Ir(I) complexes of dialkylterphenyl phosphines, 
PMe2Ar’, such as PMe2ArXyl2 and PMe2ArDipp2, demonstrates the coordination adaptability of this still 
11a·CO 11a·(CO)3 
  
 
 
understudied family of ligands, which can be viewed as hemilabiles because of the active binding 
function exerted by one of their flanking aryl rings. Besides classical κ1-P coordination, the molecules 
of PMe2Ar’ can behave as bidentate, L2, 4-electron donors in the κ1-P:κ1-Carene bonding mode 
demonstrated by X-ray crystallography for complexes 4a, 12b and 12a·(CO)3. Likewise, formally 
tetradentate κ1-P:η6-arene coordination as L4 ligands is also readily attainable, as for instance in 2a, 
11a·CO and 12a·CO. 
Our experimental and computational work also proves that changes from one coordination mode to a 
different one can be triggered by simple variations in the binding mode of other ligands, as in the 
equilibria represented in Scheme 3, or by ligand association or dissociation, e. g. Scheme 8. It therefore 
becomes apparent that terphenyl phosphines possess the potential to stabilize, through weak π-
interactions, low-coordinate intermediates which could play a crucial function in catalysis. We are 
currently exploring some catalytic applications of late transition metal complexes of terphenyl 
phosphine ligands and pursuing the synthesis of even bulkier and stronger electron-releasing PR2Ar’ 
ligands, featuring more sterically demanding alkyl substituents (R = Et, i-Pr, c-C5H9, c-C6H11 and 
others). 
Experimental Section 
General: All preparations and manipulations were carried out under oxy-gen-free nitrogen unless 
otherwise stated, using conventional Schlenk techniques and, when specified, at low temperature. 
Solvents were rigorously dried and degassed before use. Solution NMR spectra were recorded on 
Bruker Avance DPX-300, Avance DRX-400, Avance DRX-500, and 400 Ascend/R spectrometers. The 
1H and 13C resonances of the solvent were used as the internal standard and the chemical shifts are 
reported relative to TMS. [RhCl(COD)]2, [RhCl(C2H4)2]2, [IrCl(COD)]2, [IrCl(COE)2]2 
xxxiv , 
PMe2Ar
Xyl2,xxxv PMe2Ar
Dipp2 xxxvi and NaBArF 
xxxvii were prepared according to literature methods. Other 
chemicals were commercially available and used as received. CCDC nos. 1819716-1819722 contain the 
supplementary crystallographic data for compounds 2a, 7b, 11a·(CO)1, 12a·(CO)1, 12a·(CO)3, 
12b·(CO)1 and 12b·(CO)2, and CCDC no. 1820681 for compound 4a. These data can be obtained free 
of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
[Rh(cod)PMe2Ar’][BArF] (2): To a solid mixture of complex 1 (0.08 mmol) and NaBArF (0.08 mmol), 
placed in a thick-wall ampoule, was added 5 mL of CH2Cl2. The resulting solution was stirred for 10 
min at room temperature, filtered and the volatiles evaporated under reduced pressure to obtain complex 
2 as an orange (a) or yellow (b) powder in ca. 90% yield. This species can be recrystallized by slow 
diffusion of pentane into a CH2Cl2 solution at -20 ºC. 2a: Anal. Calc. for C64H51BF24PRh: C, 54.1; H, 
3.6. Found: C, 54.4; H, 3.4. 1H NMR (400 MHz, 25 ºC, CD2Cl2) δ: 7.82 (p-C6H3(COSY)), 7.57 (br, 1H, 
  
 
 
m’-C6H3), 7.30 (br, 1H, m-C6H3), 7.20 (br, 2H, m-Xyl), 6.80 (br, 2H, m-Xyl’), 5.88 (br, 1H, p-Xyl’), 
5.53 (br, 2H, CHcod), 3.44 (s, 2H, RhCHcod), 2.44 (m, 4H, CH2cod),, 2.10 (m, 4H, CH2cod), 2.16 (s, 6H, 
MeXyl’), 2.01 (s, 6H, MeXyl), 1.23 (d, 6 H, 
2JHP = 11.3 Hz, PMe2). 
1H NMR (400 MHz, 0 ºC, CD2Cl2) δ: 
7.81 (p-C6H3(COSY)), 7.59 (m, 1H, m’-C6H3), 7.30 (t, 3JHH = 7.5 Hz, 1H, p-Xyl), 7.27 (dd, 3JHH = 7.4 
Hz, 4JHP = 3.0 Hz, 1H, m-C6H3), 7.18 (d, 
3JHH = 7.5 Hz, 2H, m-Xyl), 6.75 (d, 
3JHH = 6.4 Hz, 2H, m-
Xyl’), 5.81 (m, 1H, p-Xyl’), 5.55 (m, 2H, CHcod), 3.38 (m, 2H, RhCHcod), 2.43 (m, 4H, CH2cod), 2.07 (m, 
4H, CH2cod), 2.13 (s, 6H, MeXyl’), 1.98 (s, 6H, MeXyl), 1.20 (d, 
2JHP = 11.3 Hz, 6H, PMe2). 
13C{1H} 
NMR (100 MHz, -10 ºC, CD2Cl2) δ: 146.8 (o-C6H3), 142.6 (d, 2JCP = 21 Hz, o-C6H3), 137.8 (d, 1JCP = 
50 Hz, ipso-C6H3), 137.8 (ipso-Xyl), 136.3 (o-Xyl), 133.5 (p-C6H3), 132.3 (d,
 3JCP = 6 Hz, m-C6H3), 
132.3 (CHcod), 128.6 (p-Xyl), 127.8 (m-Xyl), 127.7 (d, 
3JCP = 15 Hz, m’-C6H3), 120.5 (o-Xyl’), 116.1 
(ipso-Xyl’), 112.1 (m-Xyl’), 97.1 (d, 2JCP = 10 Hz, p-Xyl’), 74.0 (d, 1JCRh = 13 Hz, RhCHcod), 35.1 
(CH2cod), 31.7 (CH2cod), 21.1 (MeXyl), 19.5 (MeXyl’), 13.6 (d, 
1JCP = 33 Hz, PMe2). 
31P{1H} NMR (160 
MHz, −10 ºC, CD2Cl2) δ: 48.1 (d, 1JPRh = 192 Hz). 2b: Anal. Calc. for C72H67BF24PRh : C, 56.41; H, 
4.41. Found: C, 56.58; H, 4.22. 1H NMR (400 MHz, 25 ºC, CD2Cl2) δ: 7.75 (overlapped, 1H, p-C6H3), 
7.73 (s, 8H, o-Ar), 7.64 (br d, 3JHH = 7.6 Hz, 1H, m’-C6H3), 7.57 (s, 4H, p-Ar), 7.45 (t, 3JHH = 7.8 Hz, 
1H, p-Dipp), 7.39 (ddd, 3JHH = 7.6 Hz, 
4JHP = 3.3 Hz, 
4JHH = 1.1 Hz, 1H, m-C6H3), 7.27 (d, 
3JHH = 7.8 
Hz, 2H, m-Dipp), 6.76 (d, 3JHH = 6.8 Hz, 2H, m-Dipp’), 6.00 (br t, 3JHH = 6.8 Hz, 1H, p-Dipp’), 5.54 (br 
s, 2H, CHcod), 3.38 (br s, 2H, RhCHcod), 2.41 (m, 4H, CH2cod), 2.24 (m, 2H, (CHMe2)Dipp), 2.22 (m, 2H, 
(CHMe2)Dipp’), 2.05 (m, 4H, CH2cod), 1.36 (d, 
3JHH = 6.9 Hz, 6H, MeDipp’), 1.23 (m, 6H, MeDipp), 1.22 (m, 
6H, MeDipp’), 1.14 (dd, 
2JHP = 11.3 Hz, 
3JHRh = 1.3 Hz, PMe2), 1.00 (d, 
3JHH = 6.6 Hz, 6H, MeDipp). 
13C{1H} NMR (100 MHz, 25 ºC, CD2Cl2) δ: 162.2 (q, 1JCB = 50 Hz, ipso-Ar), 147.1 (o-Dipp), 145.3 (o-
C6H3), 141.9 (d, 
2JCP = 21 Hz, o-C6H3), 140.0 (d, 
1JCP = 51 Hz, ipso-C6H3), 135.5 (ipso-Dipp), 135.2 (o-
Ar), 134.2 (d, 3JCP = 6 Hz, m-C6H3), 132.0 (p-C6H3), 130.6 (p-Dipp), 129.6 (br, CHcod), 129.3 (q, 
2JCF = 
31 Hz, m-Ar), 128.6 (d, 3JCP = 15 Hz, m’-C6H3), 127.8 (br, o-Dipp’), 125.0 (q, 1JCF = 272 Hz, CF3), 
123.6 (m-Dipp), 117.9 (m, p-Ar), 113.0 (br, ipso-Dipp’), 108.9 (br, m-Dipp’), 99.2 (br, p-Dipp’), 74.7 (d, 
1JCRh = 13 Hz, RhCHcod), 35.7 (CH2cod), 31.9 (CH2cod), 31.6 ((CHMe2)Dipp), 30.1 ((CHMe2)Dipp’), 26.3 
(MeDipp), 24.9 (MeDipp’), 23.7 (MeDipp’), 21.6 (MeDipp), 15.9 (d, 
1JCP = 33 Hz, PMe2). 
31P{1H} NMR (160 
MHz, 25 ºC, CD2Cl2) δ: 48.4 (br d, 1JPRh = 192 Hz). 
[Ir(cod)PMe2Ar’][BArF] (4,5): To a solid mixture of complex 3 (0.07 mmol) and NaBArF (0.07 
mmol), placed in a thick-wall ampoule, was added 5 mL of CH2Cl2. The resulting solution was stirred 
for 10 min at room temperature, filtered and the volatiles evaporated under reduced pressure to obtain 
[Ir(cod)PMe2Ar’][BArF] (4,5) as a red (a) or orange (b) powder in ca. 85% yield. Single crystals were 
grown from a saturated hexane-dichloromethane solution. 4a,5a: Anal. Calcd. for C64H51BF24IrP: C, 
50.91; H, 3.40. Found: C, 50.61; H, 3.70. 4a: 1H NMR (400 MHz, −15 ºC, CD2Cl2) δ: 7.60 (td, 3JHH = 
  
 
 
7.6 Hz, 5JHP = 2.3 Hz, 1H, p-C6H3), 7.41 to 7.16 (br and overlapped, 6H, m-Xyl, p-Xyl), 7.15 (m-
C6H3(COSY)), 6.68 (br, 1H, m-C6H3), 3.24 (br, 2H, trans-CHcod), 3.18 (br, 2H, cis-CHcod), 1.97 (s, 6H, 
MeXyl), 1.96 (br, 6H, CH2cod(COSY)), 1.82 (s, 6H, MeXyl), 1.57 (m, 2H, CH2cod), 1.37 (d, 
1JCP = 9.8 Hz, 
6H, PMe2). 
13C{1H} NMR (100 MHz, -15 ºC, CD2Cl2) δ: 134.5 (overlapped, p-C6H3), 130.6 (d, 3JCP = 
15 Hz, m-C6H3), 103.7 (d, 
2JCP = 11 Hz, trans-CHcod), 62.3 (cis-CHcod), 33.6 (CH2cod), 28.7 (CH2cod), 
22.7 (MeXyl), 21.2 (MeXyl), 12.0 (d, 
1JCP = 37 Hz, PMe2). 
31P{1H} NMR (160 MHz, 25 ºC, CD2Cl2) δ: 
16.9 (59%). 5a: 1H NMR (500 MHz, 25 ºC, CD2Cl2) δ: 7.76 (td, 3JHH = 7.6 Hz, 5JHP = 2.1 Hz, 1H, p-
C6H3), 7.63 (m’-C6H3(COSY)), 7.30 (t, 3JHH = 7.6 Hz, 1H, p-Xyl), 7.26 (ddd, 3JHH = 7.6 Hz, 4JHP = 3.5 
Hz, 4JHH = 1.2 Hz, 1H, m-C6H3), 7.17 (d, 
3JHH = 7.6 Hz, 2H, m-Xyl), 6.63 (d, 
3JHH = 6.2 Hz, 2H, m-
Xyl’), 5.60 (m, 3H, p-Xyl’, CHcod), 2.93 (m, 2H, IrCHcod), 2.41 to 2.26 (m, 4H, CH2cod), 2.17 (s, 6H, 
MeXyl’), 1.98 (m, 2H, CH2cod(COSY)), 1.95 (s, 6H, MeXyl), 1.76 (m, 2H, CH2cod(COSY)), 1.28 (d, 
1JCP = 
11.3 Hz, 6H, PMe2). 
13C{1H} NMR (100 MHz, -15 ºC, CD2Cl2) δ: 140.1 (d, 1JCP = 59 Hz, ipso-C6H3), 
129.9 (CHcod), 127.8 (overlapped, m’-C6H3), 108.7 (o-Xyl’), 107.1 (d, 2JCP = 5 Hz, ipso-Xyl’), 105.0 (d, 
2JCP = 3 Hz, m-Xyl’), 86.2 (d, 2JCP = 10 Hz, p-Xyl’), 52.9 (IrCHcod), 36.1 (CH2cod), 32.6 (CH2cod), 21.2 
(MeXyl), 19.1 (MeXyl’), 13.0 (d, 
1JCP = 40 Hz, PMe2). 
31P{1H} NMR (160 MHz, 25 ºC, CD2Cl2) δ: 2.0 
(41%). 4b,5b: Anal. Calcd. for C72H67BF24IrP: C, 53.31; H, 4.16. Found: C, 53.28; H, 4.50. 4b: 
1H 
NMR (500 MHz, 25 ºC, CD2Cl2) δ: 3.43 (m, 2H, trans-CHcod), 3.18 (m, 2H, cis-CHcod), 2.55 (m, 2H, 
(CHMe2)Dipp), 2.38 ((CHMe2)Dipp(COSY)), 2.33 (CH2cod(COSY)), 2.28 (CH2cod(COSY)), 2.12 
(CH2cod(COSY)), 2.05 (CH2cod(COSY)),   1.37 (d, 
2JHP = 9.8 Hz, 6H, PMe2), 1.34 (MeDipp(COSY)), 1.29 
(MeDipp(COSY)), 1.11 (MeDipp(COSY)), 1.07 (MeDipp(COSY)). 
13C{1H} NMR (100 MHz, 25 ºC, 
CD2Cl2) δ: 105.4 (d, 2JCP = 11 Hz, trans-CHcod), 61.0 (cis-CHcod), 13.6 (d, 1JCP = 37 Hz, PMe2). 31P{1H} 
NMR (200 MHz, 25 ºC, CD2Cl2) δ: 14.8 (14%). 5b: 1H NMR (500 MHz, 25 ºC, CD2Cl2) δ: 7.74 
(overlapped m, 1H, m’-C6H3), 7.71 (td, 3JHH = 7.3 Hz, 5JHP = 1.8 Hz, 1H, p-C6H3), 7.46 (t, 3JHH = 7.7 Hz, 
1H, p-Dipp), 7.37 (overlapped m, 1H, m-C6H3), 7.28 (d, 
3JHH = 7.7 Hz, 2H, m-Dipp), 6.64 (d, 
3JHH = 6.3 
Hz, 2H, m-Dipp’), 5.77 (t, 3JHH = 6.3 Hz, 1H, p-Dipp’), 5.62 (m, 2H, CHcod), 2.96 (m, 2H, IrCHcod), 
2.40 (m, 4H, CH2cod), 2.25 (h, 
3JHH = 6.7 Hz, 2H, (CHMe2)Dipp), 2.13 (h, 
3JHH = 6.8 Hz, 2H, 
(CHMe2)Dipp’), 2.06 (m, 2H, CH2cod), 1.85 (m, 2H, CH2cod), 1.32 (d, 
3JHH = 6.9 Hz, 6H, MeDipp’), 1.28 (d, 
2JHP = 11.4 Hz, 6H, PMe2), 1.24 (m, 12H, MeDipp’, MeDipp), 1.00 (d, 
3JHH = 6.6 Hz, 6H, MeDipp). 
13C{1H} 
NMR (100 MHz, 25 ºC, CD2Cl2) δ: 147.2 (o-Dipp), 146.3 (o-C6H3), 142.3 (d, 1JCP = 59 Hz, ipso-C6H3), 
141.2 (d, 2JCP = 18 Hz, o-C6H3), 135.5 (ipso-Dipp), 134.7 (d, 
3JCP = 7 Hz, m-C6H3), 132.0 (p-C6H3), 
130.7 (p-Dipp), 130.4 (CHcod), 128.8 (d, 
3JCP = 7 Hz, m’-C6H3), 123.7 (m-Dipp), 120.1 (o-Dipp’), 106.9 
(d, 2JCP = 5 Hz, ipso-Dipp’), 101.7 (d, 2JCP = 4 Hz, m-Dipp’), 88.3 (d, 2JCP = 11 Hz, p-Dipp’), 53.5 
(IrCHcod), 36.7 (CH2cod), 32.8 (CH2cod), 31.7 ((CHMe2)Dipp), 29.7 ((CHMe2)Dipp’), 26.3 (MeDipp), 24.7 
(MeDipp’), 23.7 (MeDipp’), 21.6 (MeDipp), 15.3 (d, 
1JCP = 40 Hz, PMe2). 
31P{1H} NMR (200 MHz, 25 ºC, 
CD2Cl2) δ: 1.9 (86%). 
  
 
 
[Ir(cod)(py)PMe2ArXyl2][BArF] (6a): Pyridine (0.020 mmol) was added to a dichloromethane solution 
of complexes 4a and 5a (0.018 mmol), which immediately turned from red to light orange. The solution 
was stirred for 5 min at room temperature and the solvent was removed under reduced pressure. Excess 
pyridine was evaporated together with pentane (2x5 mL). The finely divided orange solid was washed 
with pentane (5 mL) and dried under reduced pressure, affording complex 6a in 82% yield. Anal. Calcd. 
for C69H56BF24IrNP: C, 52.15; H, 3.55; N, 0.88. Found: C, 52.46; H, 3.43; N, 0.69. 
1H NMR (400 MHz, 
CD2Cl2, 25 ºC) δ: 8.06 (m, 2H, 2,6-py), 7.72 (m, 9H, o-Ar, 4-py), 7.57 (td, 3JHH = 7.7 Hz, 5JHP = 1.7 Hz, 
1H, p-C6H3), 7.56 (s, 4H, p-Ar), 7.31 (m, 4H, 3,5-py, p-Xyl), 7.18 (d, 
3JHH = 7.5 Hz, 4H, m-Xyl), 7.09 
(dd, 3JHH = 7.6 Hz, 
4JHP = 3.1 Hz, 2H, m-C6H3), 3.98 (m, 2H, CHcod), 3.49 (br, 2H, CHcod), 2.28 to 2.18 
(m, 4H, CH2cod), 2.15 (s, 12H, MeXyl), 1.87 to 1.72 (m, 4H, CH2cod), 0.82 (d, 
2JHP = 8.3 Hz, 6H, PMe2). 
13C{1H} NMR (100 MHz, CD2Cl2, 25 ºC) δ: 162.2 (q, 1JCB = 50 Hz, ipso-Ar), 150.6 (2,6-py), 145.9 (d, 
2JCP = 10 Hz, o-C6H3), 141.2 (d, 
3JCP = 3 Hz, ipso-Xyl), 139.0 (4-py), 137.4 (o-Xyl), 135.2 (o-Ar), 
132.3 (d, 3JCP = 8 Hz, m-C6H3), 131.8 (d, 
4JCP = 2 Hz, p-C6H3), 129.3 (q, 
2JCF = 31 Hz, m-Ar), 129.0 (p-
Xyl), 128.4 (m-Xyl), 127.4 (3,5-py), 126.8 (d, 1JCP = 41 Hz, ipso-C6H3), 125.0 (q, 
1JCF = 272 Hz, CF3), 
117.9 (m, p-Ar), 89.7 (d, 2JCP = 13 Hz, CHcod), 66.4 (br, CHcod), 32.7 (br, CH2cod), 29.4 (br, CH2cod), 
22.4 (MeXyl), 14.3 (d, 
1JCP = 34 Hz, PMe2). 
31P{1H} NMR (160 MHz, CD2Cl2, 25 ºC) δ: -12.1. 
[Rh(C2H4)PMe2Ar’][BArF] (7): A solid mixture of [RhCl(C2H2)2]2 (0.20 mmol), PMe2Ar’ (0.40 
mmol) and NaBArF (0.40 mmol), placed in a Schlenk flask, was dissolved in CH2Cl2 (6 mL). The 
solution was stirred for 1 hour at room temperature, filtered and the solvent evaporated under reduced 
pressure to obtain complex 7 as a yellow powder in ca. 90% yield. Single crystals were grown from a 
saturated hexane-dichloromethane solution. 7a: Anal. Calc. for C58H43BF24PRh: C, 52.0; H, 3.23. 
Found: C, 52.0; H, 3.52. 1H NMR (500 MHz, 25 ºC, CD2Cl2) δ: 7.84 (td, 3JHH = 7.6 Hz, 5JHP = 2.4 Hz, 
1H, p-C6H3), 7.65 (ddd, 
3JHH = 7.7 Hz, 
4JHP = 2.3 Hz, 
4JHH = 1.3 Hz, 1H, m’-C6H3), 7.31 (m, 2H, p-Xyl, 
m-C6H3), 7.19 (d, 
3JHH = 7.6 Hz, 2H, m-Xyl), 6.96 (d, 
3JHH = 6.6 Hz, 2H, m-Xyl’), 5.54 (td, 3JHH = 6.6 
Hz, 3JHP = 2.3 Hz, 1H, p-Xyl’), 2.92 (br s, 4H, C2H4), 2.18 (s, 6H, MeXyl’), 1.99 (s, 6H, MeXyl), 1.18 (dd, 
2JHP = 11.5 Hz, 
3JHRh = 1.4 Hz, 6H, PMe2). 
13C{1H} NMR (125 MHz, 25 ºC, CD2Cl2) δ: 147.5 (o-C6H3), 
142.8 (d, 2JCP = 20 Hz, o-C6H3), 138.8 (d,
 1JCP = 52 Hz, ipso-C6H3), 137.8 (ipso-Xyl), 136.6 (o-Xyl), 
133.9 (d, 4JCP = 2 Hz, p-C6H3), 132.8 (d,
 3JCP = 6 Hz, m-C6H3), 129.0 (p-Xyl), 128.1 (m-Xyl), 128.0 
(m’-C6H3), 117.9 (o-Xyl’), 116.5 (ipso-Xyl’), 109.1 (m-Xyl’), 94.7 (d, 2JCP = 12 Hz, p-Xyl’), 46.5 (d, 
1JCRh = 13 Hz, C2H4), 21.3 (MeXyl), 19.6 (MeXyl’), 13.9 (d, 
1JCP = 33 Hz, PMe2). 
31P{1H} NMR (200 
MHz, 25 ºC, CD2Cl2) δ: 48.1 (d, 1JPRh = 185 Hz). 7b: Anal. Calc. for C66H59BF24PRh: C, 54.56; H, 4.09. 
Found: C, 54.65; H, 3.98. 1H NMR (400 MHz, 25 ºC, CD2Cl2) δ: 7.76 (td, 3JHH = 7.6 Hz, 5JHP = 2.3 Hz, 
1H, p-C6H3), 7.73 (s, 8H, o-Ar), 7.70 (ddd, 
3JHH = 7.7 Hz, 
4JHP = 2.2 Hz, 
4JHH = 1.4 Hz, 1H, m’-C6H3), 
7.57 (s, 4H, p-Ar), 7.45 (t, 3JHH = 7.8 Hz, 1H, p-Dipp), 7.41 (ddd, 
3JHH = 7.5 Hz, 
4JHP = 3.4 Hz, 
4JHH = 
  
 
 
1.4 Hz, 1H, m-C6H3), 7.27 (d, 
3JHH = 7.8 Hz, 2H, m-Dipp), 6.96 (d, 
3JHH = 6.8 Hz, 2H, m-Dipp’), 5.70 
(td, 3JHH = 6.8 Hz, 
3JHP = 2.2 Hz, 1H, p-Dipp’), 2.88 (br s, 4H, C2H4), 2.24 (m, 4H, (CHMe2)Dipp, 
(CHMe2)Dipp’), 1.32 (d, 
3JHH = 6.9 Hz, 6H, MeDipp’), 1.25 (d, 
3JHH = 6.8 Hz, 6H, MeDipp’), 1.23 (d, 
3JHH = 
6.9 Hz, 6H, MeDipp), 1.12 (dd, 
2JHP = 11.5 Hz, 
3JHRh = 1.3 Hz, 6H, PMe2), 1.00 (d, 
3JHH = 6.6 Hz, 6H, 
MeDipp). 
13C{1H} NMR (100 MHz, 25 ºC, CD2Cl2) δ: 162.2 (q, 1JCB = 50 Hz, ipso-Ar), 147.2 (o-Dipp), 
145.7 (o-C6H3), 141.8 (d, 
2JCP = 21 Hz, o-C6H3), 140.4 (d, 
1JCP = 50 Hz, ipso-C6H3), 135.2 (o-Ar, ipso-
Dipp), 134.3 (d, 3JCP = 7 Hz, m-C6H3), 132.1 (p-C6H3), 130.6 (p-Dipp), 129.3 (q, 
2JCF = 31 Hz, m-Ar), 
128.9 (o-Dipp’), 128.6 (d, 3JCP = 15 Hz, m’-C6H3), 125.0 (q, 1JCF = 272 Hz, CF3), 123.6 (m-Dipp), 117.9 
(m, p-Ar), 115.5 (t, 2JCP = 
1JCRh = 4 Hz, ipso-Dipp’), 105.0 (m-Dipp’), 96.0 (d, 2JCP = 11 Hz, p-Dipp’), 
46.0 (d, 1JCRh = 13 Hz, C2H4), 31.6 (CHMe2)Dipp), 30.1 (CHMe2)Dipp’), 26.4 (MeDipp), 25.1 (MeDipp’), 
23.7 (MeDipp’), 21.6 (MeDipp), 15.9 (d, 
1JCP = 33 Hz, PMe2). 
31P{1H} NMR (200 MHz, 25 ºC, CD2Cl2) δ: 
48.4 (d, 1JPRh = 183 Hz). 
[Ir(C2H4)PMe2Ar’][BArF] (8): Ethylene was bubbled through a deoxygenated pentane solution of 
[IrCl(coe)2]2 (0.11 mmol, 15 mL, −20 ºC) in an ampoule, until the yellow coloration fades. A red 
precipitate formed upon addition of the phosphine (0.22 mmol) dissolved in pentane (8 mL). NaBArF 
(0.22 mmol) was suspended in CH2Cl2 (8 mL) and added to the reaction mixture, which gradually 
turned pale yellow. The solution was allowed to reach room temperature and the solvent was removed 
under reduced pressure. The complex was extracted with CH2Cl2 (8 mL), the solvent evaporated under 
reduced pressure and the solid washed with pentane (10 mL), yielding complex 8 as a pure, pale solid in 
ca. 80% yield. 8a: Anal. Calc. for C58H43BF24IrP: C, 48.72; H, 3.03. Found: C, 48.92; H, 3.09. 
1H NMR 
(400 MHz, CD2Cl2, 25 ºC) δ: 7.74 (s, 8H, o-Ar), 7.73 (overlapped m, 1H, p-C6H3), 7.64 (ddd, 3JHH = 7.6 
Hz, 4JHP = 2.1 Hz, 
4JHH = 1.1 Hz, 1H, m’-C6H3), 7.56 (s, 4H, p-Ar), 7.25 (t, 3JHH = 7.7 Hz, 1H, p-Xyl), 
7.21 (ddd, 3JHH = 7.5 Hz, 
4JHP = 3.4 Hz, 
4JHH = 1.1 Hz, 1H, m-C6H3), 7.13 (d, 
3JHH = 7.6 Hz, 2H, m-Xyl), 
6.78 (d, 3JHH = 6.2 Hz, 2H, m-Xyl’), 5.30 (td, 3JHH = 6.2 Hz, 3JHP = 1.7 Hz, 1H, p-Xyl’), 2.93 (m, 2H, 
CHH=CHH), 2.18 (s, 6H, MeXyl’), 1.93 (s, 6H, MeXyl), 1.74 (m, 2H, CHH=CHH), 1.24 (d, 
2JHP = 11.4 
Hz, 6H, PMe2). 
13C{1H} NMR (100 MHz, CD2Cl2, 25 ºC) δ: 162.3 (q, 1JCB = 50 Hz, ipso-Ar), 148.4 (o-
C6H3), 142.2 (d,
 2JCP = 18 Hz, o-C6H3), 141.3 (d,
 1JCP = 59 Hz, ipso-C6H3), 137.9 (d,
 3JCP = 2 Hz, ipso-
Xyl), 136.7 (o-Xyl), 135.3 (o-Ar), 134.0 (p-C6H3), 133.3 (d,
 3JCP = 7 Hz, m-C6H3), 129.7 (p-Xyl), 129.4 
(q, 2JCF = 31 Hz, m-Ar), 128.3 (m, m’-C6H3, m-Xyl), 125.1 (q, 1JCF = 272 Hz, CF3), 118.0 (m, p-Ar), 
110.6 (o-Xyl’), 109.5 (d, 2JCP = 5 Hz, ipso-Xyl’), 102.6 (d, 2JCP = 4 Hz, m-Xyl’), 84.7 (d, 2JCP = 11 Hz, 
p-Xyl’), 24.5 (C2H4), 21.4 (MeXyl), 19.1 (MeXyl’), 13.4 (d, 1JCP = 40 Hz, PMe2). 31P{1H} NMR (160 
MHz, CD2Cl2, 25 ºC) δ: 2.1. 8b: Anal. Calc. for C66H60BF24IrP: C, 51.37; H, 3.92. Found: C, 51.40; H, 
4.07. 1H NMR (500 MHz, CD2Cl2, 25 ºC) δ: 7.77 (ddd, 3JHH = 7.6 Hz, 4JHP = 2.2 Hz, 4JHH = 1.4 Hz, 1H, 
m’-C6H3), 7.73 (td overlapped, 3JHH = 7.5 Hz, 5JHP = 2.2 Hz, 1H, p-C6H3), 7.72 (s, 8H, o-Ar), 7.56 (s, 
  
 
 
4H, p-Ar), 7.46 (t, 3JHH = 7.8 Hz, 1H, p-Dipp), 7.38 (ddd, 
3JHH = 7.3 Hz, 
4JHP = 3.6 Hz, 
4JHH = 1.3 Hz, 
1H, m-C6H3), 7.27 (d, 
3JHH = 7.8 Hz, 2H, m-Dipp), 6.88 (dd, 
3JHH = 6.4 Hz, 
3JHP = 0.7 Hz, 2H, m-Dipp’), 
5.57 (td, 3JHH = 6.4 Hz, 
3JHP = 1.7 Hz, 1H, p-Dipp’), 2.97 (m, 2H, CHH=CHH), 2.22 (h, 3JHH = 6.7 Hz, 
2H, (CHMe2)Dipp ), 2.16 (h, 
3JHH = 6.9 Hz, 2H, (CHMe2)Dipp’), 1.79 (m, 2H, CHH=CHH), 1.30 (d, 
3JHH = 
6.9 Hz, 6H, MeDipp’), 1.28 (d, 
3JHH = 6.8 Hz, 6H, MeDipp’), 1.24 (d, 
2JHP = 11.4 Hz, 6H, PMe2), 1.23 (d, 
3JHH = 6.7 Hz, 6H, MeDipp), 1.00 (d, 
3JHH = 6.7 Hz, 6H, MeDipp). 
13C{1H} NMR (100 MHz, CD2Cl2, 25 
ºC) δ: 162.3 (q, 1JCB = 50 Hz, ipso-Ar), 147.2 (o-Dipp), 146.5 (o-C6H3), 142.7 (d, 1JCP = 59 Hz, ipso-
C6H3), 141.2 (d, 
2JCP = 18 Hz, o-C6H3), 135.3 (o-Ar, ipso-Dipp (overlapped)), 134.7 (d, 
3JCP = 7 Hz, m-
C6H3), 132.1 (p-C6H3), 130.7 (p-Dipp), 129.3 (q, 
2JCF = 31 Hz, m-Ar), 128.8 (d, 
3JCP = 13 Hz, m’-C6H3), 
125.1 (q, 1JCF = 272 Hz, CF3), 123.6 (m-Dipp), 121.5 (o-Dipp’), 117.9 (m, p-Ar), 108.7 (d, 2JCP = 5 Hz, 
ipso-Dipp’), 98.3 (d, 2JCP = 4 Hz, m-Dipp’), 86.0 (d, 2JCP = 11 Hz, p-Dipp’), 31.7 ((CHMe2)Dipp), 29.8 
((CHMe2)Dipp’), 26.3 (MeDipp), 24.9 (MeDipp’), 23.9 (C2H4), 23.7 (MeDipp’), 21.5 (MeDipp), 15.3 (d, 
1JCP = 
40 Hz, PMe2). 
31P{1H} NMR (160 MHz, CD2Cl2, 25 ºC) δ: 2.1. 
[Rh(CO)PMe2Ar’][BArF] (11·CO): To a solid mixture of complex 9 (0.08 mmol) and NaBArF (0.08 
mmol), placed in a thick-wall ampoule, was added 5 mL of CH2Cl2 and the resulting solution stirred for 
10 min. After filtering, the solvent was evaporated under reduced pressure and the solid obtained 
washed with pentane (5 mL). Complex 11·CO was isolated as a yellow powder in ca. 95% yield. Single 
crystals were grown at -20 ºC by slow diffusion of pentane into a CH2Cl2 solution (2:1 by vol.). 
11a·CO: IR (Nujol): 2018 cm-1. Anal. Calc. for C57H39BF24OPRh: C, 51.1; H, 2.9. Found: C, 51.5; H, 
2.6. 1H NMR (500 MHz, 25 ºC, CD2Cl2) δ: 7.88 (td, 3JHH = 7.6, 5JHP = 2.6 Hz, 1H, p-C6H3), 7.59 (d, 
3JHH = 7.8 Hz, 1H, m’-C6H3), 7.36 (m, 2H, p-Xyl, m-C6H3), 7.23 (d, 3JHH = 7.7 Hz, 2H, m-Xyl), 7.09 (d, 
3JHH = 6.9 Hz, 2H, m-Xyl’), 6.30 (t, 3JHH = 6.7 Hz, 1H, p-Xyl’), 2.17 (s, 6H, MeXyl’) 2.01 (s, 6H, MeXyl), 
1.56 (d, 2JHP = 11.9 Hz, 6H, PMe2). 
13C{1H} NMR (125 MHz, 25 ºC, CD2Cl2) δ: 183.2 (dd, 1JCRh = 95, 
2JCP = 19 Hz, CO), 148.5 (o-C6H3), 142.8 (d, 
2JCP = 19 Hz, o-C6H3), 138.4 (d,
 1JCP = 49 Hz, ipso-C6H3), 
137.7 (o-Xyl), 135.2 (p-C6H3), 133.8 (d,
 3JCP = 7 Hz, m-C6H3), 130.5 (p-Xyl), 128.9 (m-Xyl), 128.8 (d, 
3JCP = 5 Hz, m’-C6H3), 126.5 (ipso-Xyl), 123.1 (o-Xyl’), 115.6 (ipso-Xyl’), 110.3 (m-Xyl’), 97.9 (d, 
1JCRh = 8 Hz, p-Xyl’), 22.0 (MeXyl), 20.3 (MeXyl’), 19.1 (d, 1JCP = 37 Hz, PMe2). 31P{1H} NMR (200 
MHz, 25 ºC, CD2Cl2) δ: 49.3 (d, 1JPRh = 169 Hz). 11b·CO: IR (Nujol): 2012 cm-1. Anal. Calc. for 
C65H55BF24OPRh: C, 53.7; H, 3.8. Found: C, 53.2; H, 3.7. 
1H NMR (500 MHz, 25 ºC, CD2Cl2) δ: 7.83 
(td, 3JHH = 7.6, 
5JHP = 2.6 Hz, 1H, p-C6H3), 7.68 (d, 
3JHH = 7.8 Hz, 1H, m’-C6H3), 7.53 (t, 3JHH = 7.8 Hz, 
1H, p-Dipp), 7.50 (dd, 3JHH = 7.8, 
4JHP = 3.6 Hz, 1H, m-C6H3), 7.34 (d, 
3JHH = 7.9 Hz, 2H, m-Dipp), 
7.10 (d, 3JHH = 6.9 Hz, 2H, m-Dipp’), 6.45 (t, 3JHH = 6.8 Hz, 1H, p-Dipp’), 2.26 (h, 3JHH = 6.7 Hz, 4H, 
(CHMe2)Dipp), 1.54 (d, 
2JHP = 11.9 Hz, 6H, PMe2), 1.33 (d, 
3JHH = 6.9 Hz, 6H, MeDipp’), 1.29 (d, 
3JHH = 
6.8 Hz, 6H, MeDipp), 1.26 (d, 
3JHH = 6.8 Hz, 6H, MeDipp’), 1.05 (d, 
3JHH = 6.6 Hz, 6H, MeDipp). 
13C{1H} 
  
 
 
NMR (125 MHz, 25 ºC, CD2Cl2) δ: 182.7 (dd, 1JCRh = 92, 2JCP = 18 Hz, CO), 146.8 (o-Dipp), 146.1 (o-
C6H3), 140.7 (d, 
2JCP = 20 Hz, o-C6H3), 138.7 (d,
 1JCP = 42 Hz, ipso-C6H3), 134.1 (d, 
3JCP = 7 Hz, m’-
C6H3), 133.1 (o-Dipp’), 132.3 (p-C6H3), 130.5 (p-Dipp’), 128.3 (d, 3JCP = 15 Hz, m-C6H3), 127.8 (ipso-
Dipp), 123.5 (m-Dipp), 113.2 (ipso-Dipp’), 104.7 (m-Dipp’), 97.7 (p-Dipp’), 31.3 ((CHMe2)Dipp), 29.8 
((CHMe2)Dipp’), 25.9 (MeDipp), 24.5 (MeDipp’), 23.2 (MeDipp’), 21.0 (MeDipp), 20.0 (d, 
1JCP = 37 Hz, PMe2). 
31P{1H} NMR (200 MHz, 25 ºC, CD2Cl2) δ: 49.2 (d, 1JPRh = 167 Hz). 
[Ir(CO)2PMe2Ar’][BArF] (12·(CO)2): To a solid mixture of complex 10 (0.02 mmol) and NaBArF 
(0.02 mmol), placed in a thick-wall ampoule, was added 0.7 mL of cold (a, -78 ºC; b, -30 ºC) CD2Cl2 
and the resulting solution kept cold and stirred for 30 min. The solution was filtered with cannula over 
an NMR tube placed in a dry ice/acetone bath. The spectroscopic data for this compound were collected 
at low temperature (−60 ºC, a; 0 ºC, b) for preventing CO liberation. The yield is estimated to be 
quantitative based on spectroscopic data. Analitically pure samples of this compound were obtained 
evaporating the solvent and washing with pentane at low temperature. IR data were collected from 
freshly prepared, cold CH2Cl2 solutions. 12a·(CO)2: IR (CH2Cl2): υ(Ir-CO) 2094, 2027 cm-1. Anal. 
Calcd. for C58H39BF24IrO2P: C, 47.78; H, 2.70. Found: C, 47.70; H, 2.26. 
1H NMR (400 MHz, CD2Cl2, 
−60 ºC) δ: 7.77 (d, 3JHH = ca. 7.6 Hz, 2H, m-Xyl’), 7.74 (s, 8H, o-Ar), 7.68 (t, 3JHH = 7.5 Hz, 1H, p-
C6H3), 7.54 (s, 4H, p-Ar), 7.28 (t, 
3JHH = 7.6 Hz, 2H, p-Xyl, p-Xyl’), 7.22 (dd, 3JHH = 7.0 Hz, 4JHP = 2.4 
Hz, 1H, m-C6H3), 7.16 (d, 
3JHH = 7.5 Hz, 2H, m-Xyl), 6.62 (d, 
3JHH = 6.8 Hz, 1H, m’-C6H3), 2.05 (s, 6H, 
MeXyl’), 1.94 (s, 6H, MeXyl), 1.60 (d, 
2JHP = 10.6 Hz, 6H, PMe2). 
13C{1H} NMR (100 MHz, CD2Cl2, −60 
ºC) δ: 183.0 (d, 2JCP = 102 Hz, trans-CO), 162.4 (d, 2JCP = 14 Hz, cis-CO), 161.4 (q, 1JCB = 49 Hz, ipso-
Ar), 147.2 (o-C6H3), 143.9 (d, 
2JCP = 27 Hz, o-C6H3), 139.1 (o-Xyl’), 136.2 (ipso-Xyl, o-Xyl), 135.6 (p-
C6H3), 134.3 (o-Ar), 134.2 (m-Xyl’), 133.2 (p-Xyl or p-Xyl’), 132.1 (d, 3JCP = 6 Hz, m-C6H3), 130.7 (d, 
3JCP = 15 Hz, m’-C6H3), 129.7 (d, 1JCP = 56 Hz, ipso-C6H3), 129.1 (p-Xyl or p-Xyl’), 128.3 (q, 2JCF = 31 
Hz, m-Ar), 127.5 (m-Xyl), 124.1 (q, 1JCF = 272 Hz, CF3), 117.4 (d, 
2JCP = 3 Hz, ipso-Xyl’), 117.2 (m, p-
Ar), 23.6 (MeXyl’), 21.0 (MeXyl), 14.4 (d, 
1JCP = 40 Hz, PMe2). 
31P{1H} NMR (160 MHz, CD2Cl2, −60 
ºC) δ: 16.2. 12b·(CO)2: IR (CH2Cl2): υ(Ir-CO) 2093, 2027 cm-1. Anal. Calcd. for C66H55BF24IrO2P: C, 
50.49; H, 3.53. Found: C, 50.57; H, 3.47. 1H NMR (500 MHz, CD2Cl2, 25 ºC) δ: 7.99 (d, 3JHH = 7.8 Hz, 
2H, m-Dipp’),7.72 (s, 8H, o-Ar), 7.69 (m, 1H, p-C6H3), 7.59 (t, 3JHH = 7.7 Hz, 1H, p-Dipp’), 7.56 (s, 4H, 
p-Ar), 7.54 (t, 3JHH = 8.0 Hz, 1H, p-Dipp), 7.43 (dd, 
3JHH = 7.4 Hz, 
4JHP = 3.1 Hz, 1H, m-C6H3), 7.35 (d, 
3JHH = 7.8 Hz, 2H, m-Dipp), 6.79 (d, 
3JHH = 7.6 Hz, 1H, m’-C6H3), 2.28 (h, 3JHH = 6.8 Hz, 4H, 
(CHMe2)Dipp, (CHMe2)Dipp’), 1.64 (d, 
2JHP = 10.7 Hz, 6H, PMe2), 1.56 (d, 
3JHH = 6.9 Hz, 6H, MeDipp’), 
1.31 (d, 3JHH = 6.8, 6H, MeDipp), 1.05 (d, 
3JHH = 6.6 Hz, 6H, MeDipp’), 1.03 (d, 
3JHH = 6.8 Hz, 6H, 
MeDipp). 
13C{1H} NMR (100 MHz, CD2Cl2, 0 ºC) δ: 183.0 (d, 2JCP = 102 Hz, trans-CO), 163.4 (d, 2JCP 
= 14 Hz, cis-CO), 162.0 (q, 1JCB = 50 Hz, ipso-Ar), 150.6 (o-Dipp’), 147.1 (o-Dipp), 146.5 (d, 2JCP = 2 
  
 
 
Hz, o-C6H3), 142.5 (d, 
2JCP = 26 Hz, o-C6H3), 135.0 (o-Ar), 134.6 (p-Dipp’), 134.24 (d, 3JCP = 9 Hz, m-
C6H3), 134.22 (p-C6H3), 133.8 (d, 
3JCP = 2 Hz, ipso-Dipp), 132.4 (d, 
3JCP = 15 Hz, m’-C6H3), 132.1 (d, 
1JCP = 57 Hz, ipso-C6H3), 131.3 (m-Dipp’), 130.8 (p-Dipp), 129.0 (q, 2JCF = 31 Hz, m-Ar), 124.8 (q, 1JCF 
= 272 Hz, CF3), 123.6 (m-Dipp), 118.1 (d, 
2JCP = 3 Hz, ipso-Dipp’), 117.7 (m, p-Ar), 34.6 
((CHMe2)Dipp’), 31.6 ((CHMe2)Dipp), 26.5 (MeDipp’), 26.2 (MeDipp), 24.2 (MeDipp’), 21.3 (MeDipp), 16.0 (d, 
1JCP = 40 Hz, PMe2). 
31P{1H} NMR (160 MHz, CD2Cl2, 25 ºC) δ: 15.2. 
[Ir(CO)PMe2Ar’][BArF] (12·CO): To a solid mixture of complex 10 (0.04 mmol) and NaBArF (0.04 
mmol), placed in a thick-wall ampoule, was added 5 mL of CH2Cl2 and the resulting solution stirred for 
10 min. The solution was filtered, kept under reflux and periodically opened to vacuum until CO 
liberation was complete. Solvent was removed under reduced pressure and the product washed with 
pentane to yield an air-stable, analytically pure yellow powder in ca. 85% yield. Single crystals suitable 
for X-Ray diffraction were grown by means of slow pentane diffusion in a dichloromethane solution of 
the complex at -32 ºC. This compound was also obtained pure allowing a dichloromethane solution of 
12·(CO)2 to stand in an open-air NMR tube for several days. 12a·CO: IR (Nujol): υ(Ir-CO) 2000 cm-1. 
Anal. Calcd. for C57H39BF24IrOP: C, 47.88; H, 2.75. Found: C, 47.89; H, 2.40. 
1H NMR (400 MHz, 
CD2Cl2, 25 ºC) δ: 7.83 (m, 1H, p-C6H3), 7.73 (s, 8H, o-Ar), 7.60 (m, 1H, m’-C6H3), 7.57 (s, 4H, p-Ar), 
7.34 (t, 3JHH = 7.7 Hz, 1H, p-Xyl), 7.31 (m, 1H, m-C6H3), 7.20 (d, 
3JHH = 7.6 Hz, 2H, m-Xyl), 7.04 (d, 
3JHH = 6.4 Hz, 2H, m-Xyl’), 6.09 (t, 3JHH = 6.5 Hz, 1H, p-Xyl’), 2.26 (s, 6H, MeXyl’), 1.97 (s, 6H, MeXyl), 
1.70 (d, 2JHP = 12.1 Hz, 6H, PMe2). 
13C{1H} NMR (100 MHz, CD2Cl2, 25 ºC) δ: 167.2 (d, 2JCP = 14 Hz, 
CO), 162.2 (q, 1JCB = 50 Hz, ipso-Ar), 148.9 (d, 
2JCP = 3 Hz, o-C6H3), 141.3 (d, 
2JCP = 18 Hz, o-C6H3), 
139.2 (d, 1JCP = 58 Hz, ipso-C6H3), 136.9 (d, 
3JCP = 3 Hz, ipso-Xyl), 136.7 (o-Xyl), 135.2 (o-Ar), 134.7 
(d, 4JCP = 2 Hz, p-C6H3), 133.6 (d, 
3JCP = 8 Hz, m-C6H3), 130.0 (p-Xyl), 129.3 (q, 
2JCF = 32 Hz, m-Ar), 
128.5 (m-Xyl), 128.4 (d, 3JCP = 14 Hz, m’-C6H3), 125.0 (q, 1JCF = 272 Hz, CF3), 117.9 (m, p-Ar), 116.9 
(d, 2JCP = 2 Hz, o-Xyl’), 109.7 (d, 2JCP = 5 Hz, ipso-Xyl’), 103.0 (d, 2JCP = 3 Hz, m-Xyl’), 89.1 (d, 2JCP 
= 7 Hz, p-Xyl’), 21.4 (MeXyl), 19.4 (MeXyl’), 19.3 (d, 1JCP = 43 Hz, PMe2). 31P{1H} NMR (160 MHz, 
CD2Cl2, 25 ºC) δ: 6.7. 12b·CO: IR (Nujol): υ(Ir-CO) 1997 cm-1. Anal. Calcd. for C65H55BF24IrOP: C, 
50.63; H, 3.60. Found: C, 50.35; H, 3.47. 1H NMR (400 MHz, CD2Cl2, 25 ºC) δ: 7.77 (td, 3JHH = 7.6 Hz, 
5JHP = 2.4 Hz, 1H, p-C6H3), 7.72 (s, 8H, o-Ar), 7.69 (ddd, 
3JHH = 7.6 Hz, 
4JHP = 2.3 Hz, 
4JHH = 1.2 Hz, 
1H, m’-C6H3), 7.56 (s, 4H, p-Ar), 7.50 (t, 3JHH = 7.8 Hz, 1H, p-Dipp), 7.44 (ddd, 3JHH = 7.5 Hz, 4JHP = 
3.8 Hz, 4JHH = 1.1 Hz, 1H, m-C6H3), 7.30 (d, 
3JHH = 7.8 Hz, 2H, m-Dipp), 7.04 (dd, 
3JHH = 6.6 Hz, 
3JHP 
= 0.9 Hz, 2H, m-Dipp’), 6.24 (t, 3JHH = 6.6 Hz, 1H, p-Dipp’), 2.19 (h, 3JHH = 6.6 Hz, 4H, (CHMe2)Dipp, 
(CHMe2)Dipp’), 1.67 (d, 
2JHP = 12.1 Hz, 6H, PMe2), 1.33 (d, 
3JHH = 6.9 Hz, 6H, MeDipp’), 1.26 (d, 
3JHH = 
6.7 Hz, 6H, MeDipp’), 1.25 (d,
 3JHH = 6.7 Hz, 6H, MeDipp), 1.02 (d, 
3JHH = 6.6 Hz, 6H, MeDipp). 
13C{1H} 
NMR (100 MHz, CD2Cl2, 25 ºC) δ: 167.7 (d, 2JCP = 14 Hz, CO), 162.2 (q, 1JCB = 50 Hz, ipso-Ar), 147.3 
  
 
 
(o-Dipp), 147.2 (d, 2JCP = 3 Hz, o-C6H3), 140.6 (d, 
1JCP = 58 Hz, ipso-C6H3), 140.4 (d, 
2JCP = 18 Hz, o-
C6H3), 135.3 (o-Ar), 134.9 (d, 
3JCP = 8 Hz, m-C6H3), 134.4 (d, 
3JCP = 3 Hz, ipso-Dipp), 132.7 (d, 
4JCP = 
2 Hz, p-C6H3), 131.0 (p-Dipp), 129.3 (q, 
2JCF = 31 Hz, m-Ar), 128.9 (d, 
3JCP = 14 Hz, m’-C6H3), 127.7 
(d, 2JCP = 2 Hz, o-Dipp’), 125.1 (q, 1JCF = 272 Hz, CF3), 123.7 (m-Dipp), 117.9 (m, p-Ar), 108.4 (d, 2JCP 
= 5 Hz, ipso-Xyl’), 98.4 (d, 2JCP = 3 Hz, m-Dipp’), 90.0 (d, 2JCP = 7 Hz, p-Dipp’), 31.8 ((CHMe2)Dipp), 
29.9 (CHMe2)Dipp’), 26.4 (MeDipp), 24.8 (MeDipp’), 23.7 (MeDipp’), 21. 5 (MeDipp), 21.3 (d, 
1JCP = 44 Hz, 
PMe2). 
31P{1H} NMR (160 MHz, CD2Cl2, 25 ºC) δ: 6.1. 
[Ir(CO)3PMe2Ar’][BArF] (12·(CO)3): A CH2Cl2 solution of complex 12·(CO)2 (0.02 mmol) was 
placed in a thick-wall ampoule, charged with 1.2 bar of CO and stirred for 10 min. The solvent was 
removed under reduced pressure and the product washed with pentane to yield an analytically pure 
yellow powder in ca. 85% yield. Single crystals suitable for X-Ray diffraction were grown through slow 
pentane diffusion in a dichloromethane solution of the complex at -32 ºC. The product can also be 
obtained starting from complex 12·(CO). 12a·(CO)3: IR (CH2Cl2): υ(Ir-CO) 2126, 2027 cm-1. Anal. 
Calcd. for C59H39BF24IrO3P: C, 47.69; H, 2.65. Found: C, 47.66; H, 2.19. 
1H NMR (400 MHz, CD2Cl2, 
25 ºC) δ: 7.74 (s, 8H, o-Ar), 7.71 (t, 3JHH = 7.2 Hz, 1H, p-C6H3), 7.58 (s, 4H, p-Ar), 7.47 (t, 3JHH = 7.6 
Hz, 2H, p-Xyl), 7.24 (d, 3JHH = 7.5 Hz, 4H, m-Xyl), 6.97 (br, 2H, m-C6H3), 2.11 (s, 12H, MeXyl), 1.93 (d, 
2JHP = 10.9 Hz, 6H, PMe2). 
13C{1H} NMR (100 MHz, CD2Cl2, 25 ºC) δ: 173.1 (d, 2JCP = 15 Hz, cis-CO), 
168.2 (d, 2JCP = 88 Hz, trans-CO), 162.2 (q, 
1JCB = 50 Hz, ipso-Ar), 147.4 (d, 
2JCP = 12 Hz, o-C6H3), 
140.1 (o-Xyl), 135.6 (d, 4JCP = 2 Hz, p-C6H3), 135.2 (o-Ar), 132.3 (br, ipso-Xyl), 132.1 (d,
 3JCP = 10 Hz, 
m-C6H3), 131.0 (p-Xyl), 130.4 (d, 
1JCP = 58 Hz, ipso-C6H3), 129.3 (q, 
2JCF = 31 Hz, m-Ar), 128.7 (m-
Xyl), 125.0 (q, 1JCF = 272 Hz, CF3), 117.9 (m, p-Ar), 21.9 (MeXyl), 18.1 (d, 
1JCP = 43 Hz, PMe2). 
31P{1H} NMR (160 MHz, CD2Cl2, 25 ºC) δ: -20.2. 12b·(CO)3: IR (CH2Cl2): υ(Ir-CO) 2125, 2025 cm-1. 
Anal. Calcd. for C67H55BF24IrO3P: C, 50.35; H, 3.47. Found: C, 50.47; H, 3.04. 
1H NMR (400 MHz, 
CD2Cl2, 0 ºC) δ: 7.71 (s, 8H, o-Ar), 7.64 (td, 3JHH = 7.7 Hz, 5JHP = 2.2 Hz, 1H, p-C6H3), 7.60 (t, 3JHH = 
7.8 Hz, 2H, p-Dipp), 7.56 (s, 4H, p-Ar), 7.38 (d, 3JHH = 7.9 Hz, 4H, m-Dipp), 7.19 (dd, 
3JHH = 7.7 Hz, 
4JHP = 3.5 Hz, 2H, m-C6H3), 2.41 (h, 
3JHH = 6.7 Hz, 4H, (CHMe2)Dipp), 1.83 (d, 
2JHP = 11.0 Hz, 6H, 
PMe2), 1.38 (d, 
3JHH = 6.8 Hz, 12H, MeDipp), 0.97 (d, 
3JHH = 6.6 Hz, 12H, MeDipp). 
13C{1H} NMR (100 
MHz, CD2Cl2, 0 ºC) δ: 173.2 (d, 2JCP = 14 Hz, cis-CO), 168.7 (d, 2JCP = 91 Hz, cis-CO), 161.9 (q, 1JCB 
= 50 Hz, ipso-Ar), 149.9 (br, o-Dipp), 144.4 (d, 2JCP = 11 Hz, o-C6H3), 135.0 (o-Ar), 134.0 (d, 
3JCP = 10 
Hz, m-C6H3), 132.0 (d, 
4JCP = 2 Hz, p-C6H3), 131.9 (p-Dipp), 130.9 (d, 
1JCP = 59 Hz, ipso-C6H3), 130.5 
(br, ipso-Dipp), 129.0 (q, 2JCF = 31 Hz, m-Ar), 124.8 (q, 
1JCF = 272 Hz, CF3), 124.5 (m-Dipp), 117.7 (m, 
p-Ar), 32.4 (CHMe2)Dipp), 25.8 (MeDipp), 22.6 (MeDipp), 18.5 (d, 
1JCP = 43 Hz, PMe2). 
31P{1H} NMR 
(160 MHz, CD2Cl2, 25 ºC) δ: -21.0. 
  
 
 
[Rh(CO)3PMe2Ar’][BArF] (11·(CO)3): A CD2Cl2 (0.6 mL) solution of 11·(CO) (0.08 mmol), placed 
in a Young NMR tube, was pressurized with CO (6 bar). NMR studies carried out from 25 to -60 ºC are 
in accord with the presence of complexes 11·(CO) and 11·(CO)3 (65:35 (a) or 96:4 (b)  ratio at -60 ºC). 
Complex 11·(CO)3 was only stable under a carbon monoxide atmosphere and its removal quickly 
regenerated the starting material. Consequently, characterization of 11·(CO)3 by NMR spectroscopy 
was carried out under a CO atmosphere (6 bar). 11a·(CO)3: 1H NMR (400 MHz, 25 ºC, CD2Cl2) δ: 7.75 
(td, 3JHH = 7.7, 
5JHP = 2.2 Hz, 1H, p-C6H3), 7.43 (t, 
3JHH = 7.6 Hz, 2H, p-Xyl), 7.31 (d, 
3JHH = 7.6 Hz, 
4H, m-Xyl), 7.13 (dd, 3JHH = 7.7, 
4JHP = 3.5 Hz, 1H, m-C6H3), 2.13 (s, 12 H, MeXyl), 1.63 (d, 
2JHP = 10.4 
Hz, 6H, PMe2). 
13C{1H} NMR (100 MHz, 25 ºC, CD2Cl2) δ: 182.1 (br s, CO), 146.5 (d, 2JCP = 11 Hz, o-
C6H3), 138.1 (br s, ipso-Xyl), 136.9 (o-Xyl), 133.8 (br s, p-C6H3), 131.5 (d,
 3JCP = 9 Hz, m-C6H3), 129.3 
(p-Xyl), 128.7 (m-Xyl), 127.8 (d, 1JCP = 36 Hz, ipso-C6H3), 22.4 (MeXyl). 
13C{1H} NMR (100 MHz, -60 
ºC, CD2Cl2): 180.6 (dd, 
1JCRh = 69, 
2JCP = 16 Hz, cis-CO), 178.8 (dd, 
2JCP = 92 Hz, 
1JCRh = 51 Hz, trans-
CO), 18.6 (d, 1JCP = 37 Hz, PMe2). 
31P{1H} NMR (160 MHz, 25 ºC, CD2Cl2) δ: -2.3 (br). 31P{1H} NMR 
(160 MHz, -60 ºC, CD2Cl2) δ: -1.2 (d, 1JPRh = 91 Hz). 11b·(CO)3: 31P{1H} NMR (160 MHz, -60 ºC, 
CD2Cl2) δ: -3.5 (d, 1JPRh = 91 Hz). 
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Maya, R. Peloso, E. Carmona, Polyhedron 2016, 116, 170; b) J. Campos, L. Ortega-Moreno, S. Conejero, R. Peloso, J. López- 
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